The Jean Coutu Group posts Q2 revenue gain of 2.1%

VARENNES, Quebec - The Jean Coutu Group on Wednesday posted increased revenues of 2.1% to $530 million for its second quarter ended Aug. 27, 2016.



“During  the  second  quarter,  sales  of  the  commercial  section  showed  a  significant  increase  despite  a  still  very  competitive environment, demonstrating the effectiveness of our business strategies," stated François Coutu, president  and  CEO of the Jean Coutu Group.  "We  will  continue  to  make  the  necessary  efforts  to  promote  sales  growth  and  maintain  our  leadership.”



For  the  first  half  of  fiscal  year  2017,  revenues  amounted  to  $1.1 billion, an increase of 1.8%. This increase is attributable  to  the  overall  market  growth  despite  the  deflationary  impact  on  revenues  of  the  volume  increase  in  prescriptions of generic drugs compared with brand name drugs as well as the price reductions of generic drugs, the Jean Coutu Group reported.